The Journal of Clinical Investigation found today 2 articles citing Dr. Orange research on NEMO.
Dr. Orange’s article is “Deficient natural killer cell cytotoxicity in patients with
IKK-{gamma}/NEMO mutations” published in 2002.
And the articles are:
Combined deficiency in I{kappa}B{alpha} and I{kappa}B{epsilon} reveals a
critical window of NF-{kappa}B activity in natural killer cell
differentiation
Samson, S. I., Memet, S., Vosshenrich, C. A. J., Colucci, F., Richard,
O., Ndiaye, D., Israel, A., Di Santo, J. P.
Blood 2004 103: p. 4573-4580
From the Unité des Cytokines et Développement Lymphoïde and Unité de Biologie Moléculaire de l’Expression Génique, Institut Pasteur, Paris, France.
and,
X-linked ectodermal dysplasia and immunodeficiency caused by reversion
mosaicism of NEMO reveals a critical role for NEMO in human T-cell
development and/or survival
Nishikomori, R., Akutagawa, H., Maruyama, K., Nakata-Hizume, M.,
Ohmori, K., Mizuno, K., Yachie, A., Yasumi, T., Kusunoki, T., Heike,
T., Nakahata, T.
Blood 2004 103: p. 4565-4572
From the Department of Pediatrics and Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Pediatrics, Hyogo Prefectural Tsukaguchi Hospital, Tsukaguchi, Japan; Department of Pediatrics, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan; and Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Kanazawa University, Kanazawa, Japan.
ATF